Evidence map›Paper›PMID 37309083›Full record

ArticleInternational wound journal2023

The application of MDT model for calciphylaxis management in patients with end-stage renal disease.

Yanyan Pan, Hui Wang, Yajun Ye, Manman Lv, Yamei Zhu, Ningning Wang, Jing Zhao, Jingping Shi, Xiaolin Lv

Open access · goldAbstract read
In one paragraph

Article in International wound journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yanyan PanDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hui WangDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yajun YeDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Manman LvDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yamei ZhuBlood Purification Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ningning WangDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jing ZhaoOutpatient Treatment Room, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jingping ShiDepartment of Plastic and Burn, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaolin LvDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

National key R&D projects 2017YFC1001303National Natural Science Foundation of China 81570666National Natural Science Foundation of China 81671447National Natural Science Foundation of China 81730041
6 · The paper itself

Abstract

This study focuses on the application of nurse-led multidisciplinary collaborative therapy (MDT) management model for calciphylaxis prevention of patients with terminal renal disease. Through the establishment of a multidisciplinary management team spanning nephrology department, blood purification center, dermatology department, burn and plastic surgery department, infection department, stem cell platform, nutrition department, pain department, cardiology department, hydrotherapy group, dermatology group, and outpatient treatment room, the distribution of duties among team members were clarified to bring out the best advantages of a multidisciplinary teamwork during treatment and nursing. For patients with calciphylaxis symptoms in terminal renal disease, a case-by-case management model was carried out with the focus on personalised problem. We emphasised on personalised wound care, precise medication care, active pain management, psychological intervention and palliative care, the amelioration of calcium and phosphorus metabolism disorder, nutritional supplementation, and the therapeutic intervention based on human amniotic mesenchymal stem cell regeneration. The MDT model effectively compensates for traditional nursing mode and could serve as a novel clinical management modality for calciphylaxis prevention in patients with terminal renal disease.

Indexed as

CalciphylaxisKidney Failure, ChronicHumansPainPain ManagementRenal Dialysiscalciphylaxisend-stage renal diseasehuman amniotic mesenchymal stem cellsmultidisciplinary cooperative therapypersonalised medicine

Identifiers

PMID37309083
PMCPMC10588363
OpenAlexW4380422516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.